Foresite Capital Management IV, LLC

Insider Reports History

Location
West Hollywood, CA
Signature
FORESITE CAPITAL MANAGEMENT IV, LLC, By: /s/ James B. Tananbaum, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Foresite Capital Management IV, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kinnate Biopharma Inc. 10%+ Owner Common Stock 0 $0 $2.59 03 Apr 2024 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Common Stock 1,318,983 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Warrants 34,185 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series A-1 Preferred Stock 0 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series B-1 Preferred Stock 0 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series C-1 Preferred Stock 0 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 04 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series D Preferred Stock 0 04 Feb 2026 Indirect

Insider Reports Filed by Foresite Capital Management IV, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EIKN Eikon Therapeutics, Inc. 04 Feb 2026 29 +$999,990 4 10%+ Owner 06 Feb 2026, 19:37
EIKN Eikon Therapeutics, Inc. 04 Feb 2026 0 $0 3 10%+ Owner 04 Feb 2026, 21:35
/report/000110465924044187-foresite-capital-management-iv-llc-2024-04-03 Kinnate Biopharma Inc. 03 Apr 2024 3 $0 4 10%+ Owner 05 Apr 2024, 14:15
/report/000120919123028527-foresite-capital-management-iv-llc-2023-05-08 Kinnate Biopharma Inc. 08 May 2023 2 +$4,984,000 4 10%+ Owner 10 May 2023, 17:42
/report/000120919123011565-foresite-capital-management-iv-llc-2023-02-17 Kinnate Biopharma Inc. 17 Feb 2023 1 $0 4 10%+ Owner 22 Feb 2023, 13:49